{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T01:30:26Z","timestamp":1780623026853,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,9,2]],"date-time":"2019-09-02T00:00:00Z","timestamp":1567382400000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jchf.2018.02.016","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T14:11:06Z","timestamp":1533737466000},"page":"734-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cardiac Resynchronization Therapy in\u00a0Inotrope-Dependent Heart\u00a0Failure\u00a0Patients"],"prefix":"10.1016","volume":"6","author":[{"given":"Gabriel A.","family":"Hernandez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Blumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Arcay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Monge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan F.","family":"Viles-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JoAnn","family":"Lindenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey J.","family":"Goldberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Chaparro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2018.02.016_bib1","first-page":"e38","article-title":"Heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2018.02.016_bib2","doi-asserted-by":"crossref","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","article-title":"Heart disease and stroke statistics\u20142017 update: a report from the American Heart Association","volume":"135","author":"Benjamin","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2018.02.016_bib3","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/jama.287.12.1541","article-title":"Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial","volume":"287","author":"Cuffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2018.02.016_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","article-title":"Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE)","volume":"149","author":"Adams","year":"2005","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2018.02.016_bib5","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.healun.2015.10.003","article-title":"Seventh INTERMACS annual report: 15,000 patients and counting","volume":"34","author":"Kirklin","year":"2015","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2018.02.016_bib6","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1056\/NEJMoa012175","article-title":"Long-term use of a left ventricular assist device for end-stage heart failure","volume":"345","author":"Rose","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2018.02.016_bib7","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.jacc.2015.07.075","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study","volume":"66","author":"Estep","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.jacc.2009.12.052","article-title":"Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients","volume":"55","author":"Rogers","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/MAT.0000000000000695","article-title":"Sex-specific outcome disparities in patients receiving continuous-flow left ventricular assist devices: a systematic review and meta-analysis","volume":"4","author":"Blumer","year":"2018","journal-title":"ASAIO J"},{"key":"10.1016\/j.jchf.2018.02.016_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jacc.2012.09.041","article-title":"Readmissions after implantation of axial flow left ventricular assist device","volume":"61","author":"Hasin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib11","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1161\/CIRCHEARTFAILURE.111.963272","article-title":"Should women receive left ventricular assist device support?: findings from INTERMACS","volume":"5","author":"Hsich","year":"2012","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2018.02.016_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1313385","article-title":"Unexpected abrupt increase in left ventricular assist device thrombosis","volume":"370","author":"Starling","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jchf.2018.02.016_bib13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3390\/healthcare3030750","article-title":"The importance of the management of infectious complications for patients with left ventricular assist device","volume":"3","author":"Hieda","year":"2015","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.jchf.2018.02.016_bib14","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.healun.2016.02.004","article-title":"National trends and outcomes in device-related thromboembolic complications and malfunction among heart transplant candidates supported with continuous-flow left ventricular assist devices in the United States","volume":"35","author":"Wever-Pinzon","year":"2016","journal-title":"J\u00a0Heart Lung Transplant"},{"key":"10.1016\/j.jchf.2018.02.016_bib15","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1001\/jama.297.22.2502","article-title":"Cardiac resynchronization therapy for patients with left ventricular systolic dysfunction: a systematic review","volume":"297","author":"McAlister","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2018.02.016_bib16","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.1540-8167.2006.00478.x","article-title":"CRT-D therapy in heart failure: how much do NYHA class IV patients benefit?","volume":"17","author":"Lehmann","year":"2006","journal-title":"J\u00a0Cardiovasc Electrophysiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"10.1016\/j.jchf.2018.02.016_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejheart.2008.02.006","article-title":"Cardiac resynchronisation as a rescue therapy in patients with catecholamine-dependent overt heart failure: results from a short and mid-term study","volume":"10","author":"Milliez","year":"2008","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2018.02.016_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ejheart.2004.11.005","article-title":"Cardiac resynchronization therapy: an option for inotrope-supported patients with end-stage heart failure?","volume":"7","author":"Cowburn","year":"2005","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2018.02.016_bib20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.amjcard.2007.02.058","article-title":"Cardiac resynchronization therapy in patients with end-stage inotrope-dependent class IV heart failure","volume":"100","author":"Herweg","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib21","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/clc.20965","article-title":"Clinical impact of off-label cardiac resynchronization therapy in end-stage heart failure patients on continuous intravenous inotrope","volume":"34","author":"Hara","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib22","doi-asserted-by":"crossref","first-page":"777","DOI":"10.5603\/KP.a2014.0090","article-title":"Efficacy of cardiac resynchronisation therapy in the treatment of end-stage inotrope-dependent heart failure patients","volume":"72","author":"Sokal","year":"2014","journal-title":"Kardiol Pol"},{"key":"10.1016\/j.jchf.2018.02.016_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000092616","article-title":"Urgent cardiac resynchronization therapy in patients with decompensated chronic heart failure receiving inotropic therapy: a case series","volume":"106","author":"Konstantino","year":"2006","journal-title":"Cardiology"},{"key":"10.1016\/j.jchf.2018.02.016_bib24","first-page":"342","article-title":"Effects of cardiac resynchronization therapy in patients with inotrope-dependent class IV end-stage heart failure","volume":"29","author":"Nakajima","year":"2013","journal-title":"J\u00a0Arrhythm"},{"key":"10.1016\/j.jchf.2018.02.016_bib25","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.cardfail.2010.07.253","article-title":"Role of cardiac resynchronization in end-stage heart failure patients requiring inotrope therapy","volume":"16","author":"Bhattacharya","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2018.02.016_bib26","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jclinepi.2014.03.003","article-title":"In meta-analyses of proportion studies, funnel plots were found to be an inaccurate method of assessing publication bias","volume":"67","author":"Hunter","year":"2014","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib27","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCULATIONAHA.106.629261","article-title":"Effects of cardiac resynchronization therapy with or without a defibrillator on survival and hospitalizations in patients with New York Heart Association class IV heart failure","volume":"115","author":"Lindenfeld","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2018.02.016_bib28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1540-8159.2008.01035.x","article-title":"When is it too late for cardiac resynchronization therapy?","volume":"31","author":"Herweg","year":"2008","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.jchf.2018.02.016_bib29","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1093\/eurheartj\/ehs013","article-title":"The relationship of QRS morphology and mechanical dyssynchrony to long-term outcome following cardiac resynchronization therapy","volume":"33","author":"Hara","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2018.02.016_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJMoa1602954","article-title":"Intrapericardial left ventricular assist device for advanced heart failure","volume":"376","author":"Rogers","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2018.02.016_bib31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1056\/NEJMoa1610426","article-title":"A\u00a0fully magnetically levitated circulatory pump for advanced heart failure","volume":"376","author":"Mehra","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2018.02.016_bib32","first-page":"518","article-title":"Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: the ROADMAP study 2-year results","volume":"5","author":"Starling","year":"2017","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2018.02.016_bib33","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.jacc.2017.04.025","volume":"70","author":"Yancy","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221317791830194X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221317791830194X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:50:08Z","timestamp":1761972608000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221317791830194X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S221317791830194X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2018.02.016","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac Resynchronization Therapy in\u00a0Inotrope-Dependent Heart\u00a0Failure\u00a0Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2018.02.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}